Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Supervised injection facility granted time-limited extension.

David Garmaise

    HIV/AIDS Policy & Law Review
    |March 22, 2007
    PubMed
    Summary

    Vancouver's supervised injection facility, Insite, faces an uncertain future. Despite proven health and safety benefits, the government granted a short renewal, requesting more data on its success.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Conservative government ends funding for research on Insite.

    HIV/AIDS policy & law review·2007
    Same author

    Bill eliminating conditional sentences amended to exclude drug offences.

    HIV/AIDS policy & law review·2007
    Same author

    Vancouver: Mayor proposes new treatment plan for stimulant-drug users.

    HIV/AIDS policy & law review·2007
    Same author

    Funding announcements from federal government, Gates Foundation.

    HIV/AIDS policy & law review·2007
    Same author

    Auditor-General critical of Health Canada regulatory performance.

    HIV/AIDS policy & law review·2007
    Same author

    Ottawa police accused of undermining crack distribution program.

    HIV/AIDS policy & law review·2007

    Area of Science:

    • Public Health
    • Addiction Research
    • Health Policy

    Background:

    • Insite, Vancouver's supervised injection facility, has operated under a renewable exemption.
    • The facility's long-term operational status is currently in question.
    • A three-year exemption renewal was denied by the federal government.

    Discussion:

    • The government's decision contrasts with numerous scientific studies validating Insite's positive impact.
    • Evidence supports Insite's effectiveness in improving health outcomes and public safety.
    • Further data is requested by the government to justify a longer exemption period.

    Key Insights:

    • Supervised injection sites like Insite demonstrate significant public health benefits.
    • Scientific evidence supports the efficacy of harm reduction strategies.
    • Policy decisions regarding Insite's future are contested despite empirical data.

    Outlook:

    • The ongoing debate highlights the tension between scientific evidence and policy-making in harm reduction.
    • Future research may focus on long-term impacts and specific metrics requested by policymakers.
    • The operational continuity of Insite remains a critical public health concern.

    Related Experiment Videos